Masahiko Kato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Masahiko Kato has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Yoshiharu Kinugasa
Department of Cardiovascular Medicine and Endocrinology and Metabolism, Faculty of Medicine, Tottori University, Yonago, Japan
12 shared publications Kazuhiro Yamamoto
11 shared publicationsKiyotaka Yanagihara
9 shared publications- Ichiro Hisatome
Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Institute of Regenerative Medicine and Biofunction
7 shared publications Masayuki Hirai
7 shared publications- Kazuhide Ogino
Department of Cardiology, Japanese Red Cross Tottori Hospital
6 shared publications
Latest Publications
- 1 October 2017
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (10) , S10
Frailty and Perioperative Management of Non-Cardiac Surgery
- 1 October 2017
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (10) , S10
Frailty and Perioperative Management of Non-Cardiac Surgery
- 1 October 2017
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (10) , S9
Carnitine Paradox in Patients With Heart Failure
- 1 October 2017
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (10) , S9
Carnitine Paradox in Patients With Heart Failure
- 1 October 2017
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (10) , S22
Worsening Heart Failure after Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis
- 1 October 2017
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (10) , S22
Worsening Heart Failure after Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis
- 1 September 2016
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 22 (9) , S195
Comparative Analysis of Ability to Assess Nutritional Status between CONUT and GNRI in Patients with Heart Failure
- 1 September 2016
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 22 (9) , S195
Comparative Analysis of Ability to Assess Nutritional Status between CONUT and GNRI in Patients with Heart Failure
- 1 September 2016
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 22 (9) , S169
Nutritional Assessment in Patients with Heart Failure and Exercise Intolerance -Comparative Analysis of GNRI, MNA, and CONUT-
- 1 September 2016
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 22 (9) , S169
Nutritional Assessment in Patients with Heart Failure and Exercise Intolerance -Comparative Analysis of GNRI, MNA, and CONUT-
- 1 October 2015
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 21 (10) , S173
High Hyaluronic Acid Level Predicts Adverse Clinical Outcome in Patients with Acute Decompensated Heart Failure
- 1 October 2015
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 21 (10) , S173
High Hyaluronic Acid Level Predicts Adverse Clinical Outcome in Patients with Acute Decompensated Heart Failure
- Open Access
- 17 October 2014
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 6 (1) , 113
Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study
- 17 October 2014
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 6 (1) , 113
Open AccessBezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study
- Open Access
- 27 September 2014
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 6 (1) , 106
Low serum galectin-3 concentrations are associated with insulin resistance in patients with type 2 diabetes mellitus
Galectin-3 is a family of soluble beta-galactoside-binding lectins that play many important regulatory roles in inflammation. Galectin-3-deficient mice have been shown to exhibit excess adiposity, hyperglycemia, insulin resistance and systemic inflammation. We investigated the association between serum galectin-3 and insulin resistance in patients with type 2 diabetes using a glucose clamp method. This was a cross-sectional study. Twenty patients (mean fasting plasma glucose 7.6 mmol/L, HbA1c 7.2%, BMI 28.1 kg/m2) underwent a meal tolerance test and glucose clamp test. Participants were given a test meal and plasma glucose and insulin were measured at 0, 30, 60, 120 and 180 min. The glucose disposal rate was measured during hyperinsulinemic-euglycemic glucose clamps. Serum galectin-3 levels were measured using the enzyme-linked immunosorbent assay method. The mean serum galectin-3 level was 5103 pg/ml. Galectin-3 levels correlated significantly with the glucose disposal rate (R = 0.71, P < 0.001), fasting insulin (R = −0.56, P < 0.01), homeostasis model assessment for insulin resistance (R = −0.52, P < 0.05), and the insulin sensitivity index (R = 0.62, P < 0.005). Galectin-3 levels also positively correlated with the serum adiponectin level (R = 0.61, P < 0.05), but not with the high-sensitive C-reactive protein and interleukin-6 and −10. These results suggest that low levels of serum galectin-3 are associated with insulin resistance in patients with type 2 diabetes.
- 27 September 2014
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 6 (1) , 106
Open AccessLow serum galectin-3 concentrations are associated with insulin resistance in patients with type 2 diabetes mellitus
Galectin-3 is a family of soluble beta-galactoside-binding lectins that play many important regulatory roles in inflammation. Galectin-3-deficient mice have been shown to exhibit excess adiposity, hyperglycemia, insulin resistance and systemic inflammation. We investigated the association between serum galectin-3 and insulin resistance in patients with type 2 diabetes using a glucose clamp method. This was a cross-sectional study. Twenty patients (mean fasting plasma glucose 7.6 mmol/L, HbA1c 7.2%, BMI 28.1 kg/m2) underwent a meal tolerance test and glucose clamp test. Participants were given a test meal and plasma glucose and insulin were measured at 0, 30, 60, 120 and 180 min. The glucose disposal rate was measured during hyperinsulinemic-euglycemic glucose clamps. Serum galectin-3 levels were measured using the enzyme-linked immunosorbent assay method. The mean serum galectin-3 level was 5103 pg/ml. Galectin-3 levels correlated significantly with the glucose disposal rate (R = 0.71, P < 0.001), fasting insulin (R = −0.56, P < 0.01), homeostasis model assessment for insulin resistance (R = −0.52, P < 0.05), and the insulin sensitivity index (R = 0.62, P < 0.005). Galectin-3 levels also positively correlated with the serum adiponectin level (R = 0.61, P < 0.05), but not with the high-sensitive C-reactive protein and interleukin-6 and −10. These results suggest that low levels of serum galectin-3 are associated with insulin resistance in patients with type 2 diabetes.
- Open Access
- 19 August 2014
- Published by Springer Nature in BMC Health Services Research
- Vol. 14 (1) , 1-9
Multidisciplinary intensive education in the hospital improves outcomes for hospitalized heart failure patients in a Japanese rural setting
Heart failure (HF) patients living in rural areas have a lack of HF knowledge and poor self-care because of limited medical care access. Multidisciplinary education to improve self-care behavior is indispensable for such patients. The present study evaluated whether intensive inpatient education improved outcomes of hospitalized HF patients in a Japanese rural setting. An inpatient HF management program based on multidisciplinary team intervention was applied to hospitalized HF patients in a Japanese rural area. We defined patients treated within the program from May 2009 to April 2011 as the intervention group (n = 144), and those treated with the usual care from May 2006 to April 2009 as the usual care group (n = 133). The composite endpoints of HF hospitalization and all-cause mortality were compared between the two groups. Compared with patients in the usual care group, those in the intervention group more often received the optimal interventions such as discharge use of β-blockers, cardiac rehabilitation, pre-discharge diagnostic tests, and multidisciplinary intensive education including nurse-led patient education, pharmacist’s medication teaching, and dietitian’s nutritional guidance (all P < 0.05). The incidence of the composite endpoints significantly decreased after introducing the program (P < 0.001). Among a number of interventions, multidisciplinary intensive education was the most effective intervention to improve the primary outcome (P < 0.001). Multidisciplinary intensive education is a key strategy for helping improve the outcome for Japanese HF patients in a rural setting. Our data may give a positive impact on the improvement of healthcare system in Japan.
- 19 August 2014
- Published by Springer Nature in BMC Health Services Research
- Vol. 14 (1) , 1-9
Open AccessMultidisciplinary intensive education in the hospital improves outcomes for hospitalized heart failure patients in a Japanese rural setting
Heart failure (HF) patients living in rural areas have a lack of HF knowledge and poor self-care because of limited medical care access. Multidisciplinary education to improve self-care behavior is indispensable for such patients. The present study evaluated whether intensive inpatient education improved outcomes of hospitalized HF patients in a Japanese rural setting. An inpatient HF management program based on multidisciplinary team intervention was applied to hospitalized HF patients in a Japanese rural area. We defined patients treated within the program from May 2009 to April 2011 as the intervention group (n = 144), and those treated with the usual care from May 2006 to April 2009 as the usual care group (n = 133). The composite endpoints of HF hospitalization and all-cause mortality were compared between the two groups. Compared with patients in the usual care group, those in the intervention group more often received the optimal interventions such as discharge use of β-blockers, cardiac rehabilitation, pre-discharge diagnostic tests, and multidisciplinary intensive education including nurse-led patient education, pharmacist’s medication teaching, and dietitian’s nutritional guidance (all P < 0.05). The incidence of the composite endpoints significantly decreased after introducing the program (P < 0.001). Among a number of interventions, multidisciplinary intensive education was the most effective intervention to improve the primary outcome (P < 0.001). Multidisciplinary intensive education is a key strategy for helping improve the outcome for Japanese HF patients in a rural setting. Our data may give a positive impact on the improvement of healthcare system in Japan.